ANAB
Anaptysbio, Inc.
Clinical-stage biotechnology company focused on immunology therapeutics
CUSIP: 032724106HealthcareUS1 holder
Total Value
$45.13M
Total Shares
799.9K
Net Share Change
-30.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$45.13M799.9K shares
TRIM-30.3K(-3.6%)